Variant report

Variant	esv3416470
Chromosome Location	chr2:86115141-86117289
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:86116245-86116427	HepG2	liver:	n/a	n/a
2	ARID3A	chr2:86116210-86116549	K562	blood:	n/a	n/a
3	ATF2	chr2:86116023-86116686	GM12878	blood:	n/a	chr2:86116165-86116176
4	ATF2	chr2:86116021-86116670	GM12878	blood:	n/a	chr2:86116165-86116176
5	ATF3	chr2:86116000-86116404	HepG2	liver:	n/a	chr2:86116167-86116175 chr2:86116164-86116175 chr2:86116165-86116176 chr2:86116167-86116174 chr2:86116155-86116175 chr2:86116304-86116313 chr2:86116163-86116178
6	ATF3	chr2:86115874-86116310	K562	blood:	n/a	chr2:86116167-86116175 chr2:86116164-86116175 chr2:86116165-86116176 chr2:86116167-86116174 chr2:86116155-86116175 chr2:86116163-86116178
7	BACH1	chr2:86115450-86116003	H1-hESC	embryonic stem cell:	n/a	n/a
8	BACH1	chr2:86116389-86116455	K562	blood:	n/a	n/a
9	BCL11A	chr2:86116103-86116591	GM12878	blood:	n/a	chr2:86116305-86116314 chr2:86116120-86116133 chr2:86116314-86116327
10	BCL3	chr2:86116113-86116949	A549	lung:	n/a	chr2:86116305-86116314 chr2:86116120-86116133 chr2:86116314-86116327
11	BCLAF1	chr2:86116004-86116707	GM12878	blood:	n/a	chr2:86116305-86116314 chr2:86116120-86116133 chr2:86116314-86116327
12	BHLHE40	chr2:86115800-86116770	GM12878	blood:	n/a	chr2:86115890-86115906 chr2:86116109-86116125
13	BHLHE40	chr2:86116920-86117020	K562	blood:	n/a	n/a
14	BHLHE40	chr2:86115913-86116712	K562	blood:	n/a	chr2:86116109-86116125
15	BHLHE40	chr2:86114726-86115343	GM12878	blood:	n/a	n/a
16	BHLHE40	chr2:86114745-86115454	K562	blood:	n/a	n/a
17	BRCA1	chr2:86116136-86116363	GM12878	blood:	n/a	n/a
18	CCNT2	chr2:86115672-86116496	K562	blood:	n/a	n/a
19	CEBPB	chr2:86117210-86117470	HepG2	liver:	n/a	n/a
20	CEBPB	chr2:86116202-86116840	IMR90	lung:	n/a	n/a
21	CEBPB	chr2:86116408-86116712	K562	blood:	n/a	n/a
22	CEBPB	chr2:86117152-86117459	A549	lung:	n/a	n/a
23	CEBPB	chr2:86116255-86116829	Hela-S3	cervix:	n/a	n/a
24	CEBPB	chr2:86116016-86116821	A549	lung:	n/a	n/a
25	CEBPB	chr2:86116084-86116359	HepG2	liver:	n/a	n/a
26	CEBPB	chr2:86115290-86115486	H1-hESC	embryonic stem cell:	n/a	n/a
27	CEBPB	chr2:86116010-86116528	HepG2	liver:	n/a	n/a
28	CEBPB	chr2:86115969-86116810	MCF-7	breast:	n/a	n/a
29	CEBPB	chr2:86116032-86116972	A549	lung:	n/a	n/a
30	CEBPD	chr2:86116039-86116404	HepG2	liver:	n/a	n/a
31	CEBPD	chr2:86115867-86116421	HepG2	liver:	n/a	n/a
32	CHD1	chr2:86115508-86115697	H1-hESC	embryonic stem cell:	n/a	n/a
33	CHD1	chr2:86114892-86115500	GM12878	blood:	n/a	n/a
34	CHD1	chr2:86115929-86116820	GM12878	blood:	n/a	n/a
35	CHD2	chr2:86116117-86116337	K562	blood:	n/a	n/a
36	CHD2	chr2:86116084-86116456	H1-hESC	embryonic stem cell:	n/a	n/a
37	CHD2	chr2:86116577-86116591	K562	blood:	n/a	n/a
38	CHD2	chr2:86116053-86116276	HepG2	liver:	n/a	n/a
39	CHD2	chr2:86115711-86116787	GM12878	blood:	n/a	n/a
40	CHD2	chr2:86115914-86116374	Hela-S3	cervix:	n/a	n/a
41	CREB1	chr2:86116078-86116455	A549	lung:	n/a	chr2:86116164-86116177
42	CREB1	chr2:86115669-86116732	HepG2	liver:	n/a	chr2:86116164-86116177
43	CREB1	chr2:86115734-86116752	H1-hESC	embryonic stem cell:	n/a	chr2:86116164-86116177
44	CREB1	chr2:86115686-86116680	GM12878	blood:	n/a	chr2:86116164-86116177
45	CREB1	chr2:86115731-86116496	H1-hESC	embryonic stem cell:	n/a	chr2:86116164-86116177
46	CREB1	chr2:86115804-86116473	K562	blood:	n/a	chr2:86116164-86116177
47	CREB1	chr2:86115684-86116521	A549	lung:	n/a	chr2:86116164-86116177
48	CREB1	chr2:86115870-86116603	K562	blood:	n/a	chr2:86116164-86116177
49	CTBP2	chr2:86115432-86116604	H1-hESC	embryonic stem cell:	n/a	n/a
50	CTCF	chr2:86115922-86116012	Lung_OC	lung:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:86116049-86116099	HCT-116	colon:	n/a
2	chr2:86116326-86116376	Hela-S3	cervix:	n/a
3	chr2:86116777-86116827	GM06990	blood:	n/a
4	chr2:86115700-86115750	HepG2	liver:	n/a
5	chr2:86115700-86115750	AoSMC	blood vessel:	n/a
6	chr2:86116472-86116522	NHDF-neo	bronchial:	n/a
7	chr2:86116495-86116545	HRPEpiC	eye:	n/a
8	chr2:86116384-86116434	HCPEpiC	choroid plexus:	n/a
9	chr2:86116326-86116376	SK-N-MC	brain:	n/a
10	chr2:86115700-86115750	ProgFib	skin:	n/a
11	chr2:86116472-86116522	SK-N-MC	brain:	n/a
12	chr2:86115700-86115750	T-47D	breast:	n/a
13	chr2:86116071-86116121	K562	blood:	n/a
14	chr2:86116384-86116434	AG04450	lung:	fetal
15	chr2:86116326-86116376	HRPEpiC	eye:	n/a
16	chr2:86116777-86116827	A549	lung:	n/a
17	chr2:86116777-86116827	GM12878	blood:	n/a
18	chr2:86115700-86115750	NT2-D1	testis:	n/a
19	chr2:86115591-86115641	HRPEpiC	eye:	n/a
20	chr2:86116049-86116099	HMEC	breast:	n/a
21	chr2:86116624-86116674	IMR90	lung:	fetal
22	chr2:86116071-86116121	AG04450	lung:	fetal
23	chr2:86116071-86116121	CMK	blood:	n/a
24	chr2:86115509-86115559	SKMC	muscle:	n/a
25	chr2:86116071-86116121	GM12892	blood:	n/a
26	chr2:86116326-86116376	GM12892	blood:	n/a
27	chr2:86116326-86116376	SKMC	muscle:	n/a
28	chr2:86116049-86116099	HCM	heart:	n/a
29	chr2:86116049-86116099	SK-N-MC	brain:	n/a
30	chr2:86116624-86116674	GM06990	blood:	n/a
31	chr2:86116326-86116376	HRCEpiC	kidney:	n/a
32	chr2:86116384-86116434	SK-N-SH_RA	brain:	n/a
33	chr2:86116071-86116121	MCF10A-Er-Src	breast:	n/a
34	chr2:86116624-86116674	HL-60	blood:	n/a
35	chr2:86116495-86116545	HCT-116	colon:	n/a
36	chr2:86116049-86116099	AG04450	lung:	fetal
37	chr2:86116326-86116376	AG04449	skin:	fetal
38	chr2:86116495-86116545	MCF-7	breast:	n/a
39	chr2:86116777-86116827	H1-hESC	embryonic stem cell:	embryo
40	chr2:86116495-86116545	HNPCEpiC	eye:	n/a
41	chr2:86116495-86116545	SK-N-SH	brain:	n/a
42	chr2:86116495-86116545	A549	lung:	n/a
43	chr2:86115700-86115750	CMK	blood:	n/a
44	chr2:86116777-86116827	SAEC	small airway:	n/a
45	chr2:86115509-86115559	NB4	blood:	n/a
46	chr2:86116500-86116550	AG04450	lung:	fetal
47	chr2:86115509-86115559	NHDF-neo	bronchial:	n/a
48	chr2:86116500-86116550	AG09309	skin:	n/a
49	chr2:86116071-86116121	AG10803	skin:	n/a
50	chr2:86115700-86115750	NH-A	brain:	n/a

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ATOH8-2	chr2:86116278-86116792	XLOC_001558
2	lnc-ATOH8-2	chr2:86116403-86116926	XLOC_001558
3	lnc-ATOH8-2	chr2:86116403-86116926	XLOC_001558
4	lnc-ATOH8-2	chr2:86116278-86116930	XLOC_001558
5	lnc-ATOH8-2	chr2:86116411-86116926	NONHSAT072069
6	lnc-ATOH8-2	chr2:86116545-86116926	XLOC_001558
7	lnc-ATOH8-2	chr2:86116394-86116926	XLOC_001558
8	lnc-ATOH8-2	chr2:86116470-86116926	NONHSAT072070
9	lnc-ATOH8-2	chr2:86116160-86118475	NONHSAT072061
10	lnc-ATOH8-2	chr2:86116403-86116926	ENSG00000232504
11	lnc-ATOH8-2	chr2:86116376-86117443	XLOC_001558
12	lnc-POLR1A-7	chr2:86115947-86116031	NONHSAT072056
13	lnc-ATOH8-2	chr2:86116399-86116926	NONHSAT072065

Variant related genes	Relation type
ST3GAL5	TF binding region
ENSG00000232504	TF binding region
ST3GAL5	CpG island
ENSG00000232504	CpG island
WEE1	miRNA target sites
SPRED1	miRNA target sites
SLC30A7	miRNA target sites
ZCCHC2	miRNA target sites
PML	miRNA target sites

Extended variants
information (count: 67 )
Associated
traits (count: 50 )

Variant overlapped rSNPs/rCNVs (count:67 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs13024577	chr2:86115185-86115186	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
2	rs13025122	chr2:86115202-86115203	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
3	rs59317756	chr2:86115214-86115215	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs554320172	chr2:86115220-86115221	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
5	rs544525183	chr2:86115249-86115250	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs545071302	chr2:86115262-86115263	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs546294971	chr2:86115268-86115269	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
8	rs565121822	chr2:86115275-86115276	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
9	rs114952406	chr2:86115311-86115312	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
10	rs13024999	chr2:86115314-86115315	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs72934709	chr2:86115330-86115331	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs529657010	chr2:86115394-86115395	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs547756513	chr2:86115493-86115494	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs548234564	chr2:86115509-86115510	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
15	rs141899465	chr2:86115519-86115520	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
16	rs527419625	chr2:86115545-86115546	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
17	rs75051766	chr2:86115551-86115552	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
18	rs371511398	chr2:86115576-86115577	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs571073855	chr2:86115594-86115595	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
20	rs531767584	chr2:86115606-86115607	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
21	rs191905566	chr2:86115616-86115617	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
22	rs150185316	chr2:86115634-86115635	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
23	rs535869904	chr2:86115644-86115645	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs183691333	chr2:86115646-86115647	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs566062635	chr2:86115654-86115655	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs539962252	chr2:86115737-86115738	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
27	rs143747207	chr2:86115741-86115742	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
28	rs557966118	chr2:86115742-86115743	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
29	rs116545447	chr2:86115764-86115765	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs544036585	chr2:86115808-86115809	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs116892869	chr2:86115842-86115843	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs528674476	chr2:86115858-86115859	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs574420693	chr2:86115866-86115867	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs138722478	chr2:86115870-86115871	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs559756386	chr2:86115992-86115993	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
36	rs527286367	chr2:86116043-86116044	Bivalent/Poised TSS Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs545883974	chr2:86116080-86116081	Bivalent/Poised TSS Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
38	rs562582389	chr2:86116094-86116095	Bivalent/Poised TSS Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
39	rs563982857	chr2:86116099-86116100	Bivalent/Poised TSS Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
40	rs531951876	chr2:86116111-86116112	Bivalent/Poised TSS Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
41	rs550081257	chr2:86116161-86116162	Bivalent/Poised TSS Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
42	rs28364795	chr2:86116168-86116169	Bivalent/Poised TSS Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs28364794	chr2:86116169-86116170	Bivalent/Poised TSS Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs113380778	chr2:86116215-86116216	Bivalent/Poised TSS Active TSS	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
45	rs189132172	chr2:86116304-86116305	Bivalent/Poised TSS Active TSS	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
46	rs571584949	chr2:86116315-86116316	Bivalent/Poised TSS Active TSS	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
47	rs192061482	chr2:86116329-86116330	Bivalent/Poised TSS Active TSS	TF binding region CpG island lncRNA	2 gene(s)	Overlapped CNVs	n/a
48	rs539404876	chr2:86116334-86116335	Bivalent/Poised TSS Active TSS	TF binding region CpG island lncRNA	2 gene(s)	Overlapped CNVs	n/a
49	rs558241428	chr2:86116359-86116360	Bivalent/Poised TSS Active TSS	TF binding region CpG island lncRNA	2 gene(s)	Overlapped CNVs	n/a
50	rs556673609	chr2:86116369-86116370	Bivalent/Poised TSS Active TSS	TF binding region CpG island lncRNA	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:50)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Medulloblastoma	20607354	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Lung cancer	18438408	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	16272173	CNVD
Breast cancer	20409316	CNVD
Breast cancer	21990379	CNVD
Astrocytoma	22246337	CNVD
Papillary thyroid carcinoma	22161024	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	21399695	CNVD
Breast cancer	21364760	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:410 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:86102800-86115200	Weak transcription	Small Intestine	intestine
2	chr2:86106400-86115200	Weak transcription	Gastric	stomach
3	chr2:86113000-86115400	Flanking Active TSS	Brain Hippocampus Middle	brain
4	chr2:86113000-86115600	Flanking Active TSS	Dnd41	blood
5	chr2:86113400-86115600	Flanking Active TSS	HSMM	muscle
6	chr2:86113600-86115200	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
7	chr2:86113600-86115600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr2:86113600-86115600	Flanking Active TSS	Fetal Thymus	thymus
9	chr2:86113600-86115600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
10	chr2:86113600-86115800	Flanking Active TSS	NH-A	brain
11	chr2:86113800-86115200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
12	chr2:86113800-86115400	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
13	chr2:86113800-86115400	Flanking Active TSS	Rectal Smooth Muscle	rectum
14	chr2:86113800-86115400	Flanking Active TSS	HSMMtube	muscle
15	chr2:86113800-86115400	Flanking Active TSS	NHEK	skin
16	chr2:86113800-86115600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
17	chr2:86113800-86115600	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
18	chr2:86113800-86115600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
19	chr2:86113800-86115600	Flanking Active TSS	Fetal Muscle Leg	muscle
20	chr2:86113800-86115600	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
21	chr2:86113800-86115800	Flanking Active TSS	Adipose Nuclei	Adipose
22	chr2:86113800-86115800	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
23	chr2:86113800-86115800	Flanking Active TSS	HMEC	breast
24	chr2:86113800-86116800	Active TSS	Left Ventricle	heart
25	chr2:86114000-86115400	Flanking Active TSS	NHDF-Ad	bronchial
26	chr2:86114000-86115400	Flanking Active TSS	Osteobl	bone
27	chr2:86114000-86115600	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr2:86114000-86115600	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
29	chr2:86114000-86115600	Flanking Active TSS	K562	blood
30	chr2:86114000-86115800	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
31	chr2:86114000-86115800	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
32	chr2:86114000-86115800	Flanking Active TSS	Muscle Satellite Cultured Cells	--
33	chr2:86114000-86115800	Flanking Active TSS	NHLF	lung
34	chr2:86114000-86117200	Active TSS	Lung	lung
35	chr2:86114000-86117800	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
36	chr2:86114200-86115200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
37	chr2:86114200-86115200	Active TSS	Colonic Mucosa	Colon
38	chr2:86114200-86115600	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
39	chr2:86114200-86116800	Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
40	chr2:86114200-86117400	Active TSS	Psoas Muscle	Psoas
41	chr2:86114200-86117800	Active TSS	Brain Angular Gyrus	brain
42	chr2:86114200-86117800	Active TSS	Right Atrium	heart
43	chr2:86114400-86115600	Flanking Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
44	chr2:86114400-86115600	Flanking Bivalent TSS/Enh	GM12878-XiMat	blood
45	chr2:86114400-86115800	Flanking Active TSS	Primary B cells from cord blood	blood
46	chr2:86114600-86115200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr2:86114600-86115200	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
48	chr2:86114600-86115200	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
49	chr2:86114600-86115200	Flanking Active TSS	Brain Germinal Matrix	brain
50	chr2:86114600-86115200	Flanking Active TSS	Stomach Mucosa	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links